Trademark Overview
On Wednesday, March 4, 2026, a trademark application was filed for TYLTREEVA with the United States Patent and Trademark Office. The USPTO has given the TYLTREEVA trademark a serial number of 99683131. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, March 4, 2026. This trademark is owned by Pfizer Inc.. The TYLTREEVA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, pulmonary, respiratory, and viral diseases and disorders;; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, asthma, cancer, cachexia, chronic obstructive pulmonary disease (COPD), eczema, hypertension, migraine, pain, stroke, obesity and diabetes;
